AAAAAA

   
Results: << | 401-425 | 426-450 | 451-475 | 476-500 | >>

Table of contents of journal: *Cancer immunology and immunotherapy

Results: 401-425/568

Authors: VANDERSCHUEREN B DUMON JC OLEFFE V HEYMANS C GERAIN J BODY JJ
Citation: B. Vanderschueren et al., CIRCULATING CONCENTRATIONS OF INTERLEUKIN-6 IN CANCER-PATIENTS AND THEIR PATHOGENIC ROLE IN TUMOR-INDUCED HYPERCALCEMIA, Cancer immunology and immunotherapy, 39(5), 1994, pp. 286-290

Authors: TSAI SCJ HEPPNER GH
Citation: Scj. Tsai et Gh. Heppner, IMMUNOENDOCRINE MECHANISMS IN MAMMARY-TUMOR PROGRESSION - DIRECT PROLACTIN MODULATION OF PERIPHERAL AND PRENEOPLASTIC HYPERPLASTIC-ALVEOLAR-NODULE-INFILTRATING LYMPHOCYTES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 291-298

Authors: AUDRAN R DAZORD L TOUJAS L
Citation: R. Audran et al., INTERACTIONS BETWEEN HUMAN MACROPHAGES AND TUMOR-CELLS IN 3-DIMENSIONAL CULTURES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 299-304

Authors: VOLLENWEIDER I MOSER R GROSCURTH P
Citation: I. Vollenweider et al., DEVELOPMENT OF 4 DONOR-SPECIFIC PHENOTYPES IN HUMAN LONG-TERM LYMPHOKINE-ACTIVATED KILLER-CELL CULTURES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 305-312

Authors: OKADA H YOSHIDA J SEO H WAKABAYASHI T SUGITA K HAGIWARA M
Citation: H. Okada et al., ANTI-(GLIOMA SURFACE-ANTIGEN) MONOCLONAL-ANTIBODY G-22 RECOGNIZES OVEREXPRESSED CD44 IN GLIOMA-CELLS, Cancer immunology and immunotherapy, 39(5), 1994, pp. 313-317

Authors: DILAZZARO C DIGIESI G TECCE R LOTTI LV TORRISI MR NATALI PG
Citation: C. Dilazzaro et al., IMMUNOTOXINS TO THE HER-2 ONCOGENE PRODUCT - FUNCTIONAL AND ULTRASTRUCTURAL ANALYSIS OF THEIR CYTOTOXIC ACTIVITY, Cancer immunology and immunotherapy, 39(5), 1994, pp. 318-324

Authors: ONG GL MARRIA V MATTES MJ
Citation: Gl. Ong et al., THE FATE OF ANTIBODIES AND THEIR RADIOLABELS BOUND TO TUMOR-CELLS IN-VITRO - THE EFFECT OF CROSS-LINKING AT THE CELL-SURFACE AND OF ANTIIDIOTYPE ANTIBODIES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 325-331

Authors: ZENG ZC TANG ZY LIU KD LU JZ CAI XJ XIE H
Citation: Zc. Zeng et al., HUMAN ANTI-(MURINE IG) ANTIBODY-RESPONSES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA RECEIVING INTRAHEPATIC ARTERIAL I-131-LABELED HEPAMA-1 MAB - PRELIMINARY-RESULTS AND DISCUSSION, Cancer immunology and immunotherapy, 39(5), 1994, pp. 332-336

Authors: JACKEL M KOPFMAIER P TAUSCHTREML R
Citation: M. Jackel et al., LACK OF CELL-CYCLE-SPECIFIC EFFECTS OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN-VIVO, Cancer immunology and immunotherapy, 39(5), 1994, pp. 337-341

Authors: STUHLER G WALDEN P
Citation: G. Stuhler et P. Walden, RECRUITMENT OF HELPER T-CELLS FOR INDUCTION OF TUMOR REJECTION BY CYTOLYTIC T-LYMPHOCYTES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 342-345

Authors: JANSSEN RAJ MULDER NH THE TH DELEIJ L
Citation: Raj. Janssen et al., THE IMMUNOBIOLOGICAL EFFECTS OF INTERLEUKIN-2 IN-VIVO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 207-216

Authors: PURASIRI P ASHBY J HEYS SD EREMIN O
Citation: P. Purasiri et al., EFFECT OF ESSENTIAL FATTY-ACIDS ON CIRCULATING T-CELL SUBSETS IN PATIENTS WITH COLORECTAL-CANCER, Cancer immunology and immunotherapy, 39(4), 1994, pp. 217-222

Authors: SCHEID C PRENDIVILLE J JAYSON G CROWTHER D FOX B PETTIT GR STERN PL
Citation: C. Scheid et al., IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN-1 IN A PHASE-I CLINICAL-STUDY - COMPARISON WITH EFFECTS OF BRYOSTATIN-1 ON LYMPHOCYTE FUNCTION IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 223-230

Authors: HUANG SY SINGH RK XIE KP GUTMAN M BERRY KK BUCANA CD FIDLER IJ BARELI M
Citation: Sy. Huang et al., EXPRESSION OF THE JE MCP-1 GENE SUPPRESSES METASTATIC POTENTIAL IN MURINE COLON-CARCINOMA CELLS/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 231-238

Authors: SCHOLLER J STRATEN PT BIRCK A SIIM E DAHLSTROM K DRZEWIECKI KT ZEUTHEN J
Citation: J. Scholler et al., ANALYSIS OF T-CELL RECEPTOR-ALPHA-BETA VARIABILITY IN LYMPHOCYTES INFILTRATING MELANOMA PRIMARY TUMORS AND METASTATIC LESIONS, Cancer immunology and immunotherapy, 39(4), 1994, pp. 239-248

Authors: KURISU H MATSUYAMA H OHMOTO Y SHIMABUKURO T NAITO K
Citation: H. Kurisu et al., CYTOKINE-MEDIATED ANTITUMOR EFFECT OF BACILLUS-CALMETTE-GUERIN ON TUMOR-CELLS IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 249-253

Authors: RAGNHAMMAR P FRODIN JE TROTTA PP MELLSTEDT H
Citation: P. Ragnhammar et al., CYTOTOXICITY OF WHITE BLOOD-CELLS ACTIVATED BY GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AND MACROPHAGE-COLONY-STIMULATING FACTOR AGAINST TUMOR-CELLS IN THE PRESENCE OF VARIOUS MONOCLONAL-ANTIBODIES/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 254-262

Authors: FIERLBECK G SCHREINER T SCHABER B WALSER A RASSNER G
Citation: G. Fierlbeck et al., NEUTRALIZING INTERFERON-BETA ANTIBODIES IN MELANOMA PATIENTS TREATED WITH RECOMBINANT AND NATURAL INTERFERON-BETA, Cancer immunology and immunotherapy, 39(4), 1994, pp. 263-268

Authors: LEE YC LUH SP WU RM LEE CJ
Citation: Yc. Lee et al., ADJUVANT IMMUNOTHERAPY WITH INTRAPLEURAL STREPTOCOCCUS-PYOGENES (OK-432) IN LUNG-CANCER PATIENTS AFTER RESECTION, Cancer immunology and immunotherapy, 39(4), 1994, pp. 269-274

Authors: KOWALCZYK D SKORUPSKI W DREWS M NOWAK J
Citation: D. Kowalczyk et al., DIFFERENT PATTERN OF T-CELL RECEPTOR DELTA-GENE REARRANGEMENT IN TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD IN PATIENTS WITH SOLIDTUMORS, Cancer immunology and immunotherapy, 39(4), 1994, pp. 275-278

Authors: BERD D MAGUIRE HC MASTRANGELO MJ MURPHY G
Citation: D. Berd et al., ACTIVATION MARKERS ON T-CELLS INFILTRATING MELANOMA METASTASES AFTER THERAPY WITH DINITROPHENYL-CONJUGATED VACCINE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 141-147

Authors: FLEISCHMANN CM STANTON GJ FLEISCHMANN WR
Citation: Cm. Fleischmann et al., ENHANCED IN-VIVO SENSITIVITY TO INTERFERON WITH IN-VITRO RESISTANT B16 TUMOR-CELLS IN MICE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 148-154

Authors: TOHKIN M KAKUDO S KASAI H ARITA H
Citation: M. Tohkin et al., COMPARATIVE-STUDY OF INHIBITORY EFFECTS BY MURINE INTERFERON-GAMMA AND A NEW BISPHOSPHONATE (ALENDRONATE) IN HYPERCALCEMIC, NUDE-MICE BEARING HUMAN TUMOR (LJC-1-JCK), Cancer immunology and immunotherapy, 39(3), 1994, pp. 155-160

Authors: KATANO M MATSUO T MORISAKI T NAITO K NAGUMO F KUBOTA E NAKAMURA M HISATSUGU T TADANO J
Citation: M. Katano et al., INCREASED PROLIFERATION OF A HUMAN BREAST-CARCINOMA CELL-LINE BY RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 39(3), 1994, pp. 161-166

Authors: CLEMENTI E BUCCI E CITTERIO G LANDONIO G CONSOGNO G FORTIS C
Citation: E. Clementi et al., REVERSIBLE ANERGY IN CIRCULATING LYMPHOCYTES OF CANCER-PATIENTS DURING INTERLEUKIN-2 THERAPY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 167-171
Risultati: << | 401-425 | 426-450 | 451-475 | 476-500 | >>